VentriPoint Diagnostics Ltd-医療機器分野:企業M&A・提携分析

◆英語タイトル:VentriPoint Diagnostics Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010934
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
VentriPoint Diagnostics Ltd (Ventripoint) is a medical device company that manufactures and distributes diagnostic tools and monitoring devices for patients with heart diseases. The company offers ventripoint diagnostic system, which is a cardiovascular monitoring and measurement device. Its manufactured device provides three-dimensional models and volume measurements of the heart ventricles using 2D and 3D imaging equipment. VentriPoint uses knowledge based reconstruction technology that offers a method for rapid measurement of right ventricular volume and function in patients with congenital heart disease. The company sells its products through its distributors in the US, Canada, and other countries. VentriPoint is headquartered in Bellevue, Washington, the US.

VentriPoint Diagnostics Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
VentriPoint Diagnostics Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
VentriPoint Diagnostics Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
VentriPoint Diagnostics Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
VentriPoint Diagnostics Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
VentriPoint Diagnostics Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
VentriPoint Diagnostics Ltd, Medical Equipment, Deal Details 10
Partnerships 10
VentriPoint Diagnostics Enters into Licensing Agreement with University of Washington 10
VentriPoint Diagnostics Enters Into Co-Development Agreement For 2D Ultrasound-VMS 11
Equity Offering 12
Ventripoint Diagnostics to Raise USD2.4 Million in Private Placement of Units 12
Ventripoint Diagnostics Raises USD0.2 Million in First Tranche Private Placement of Shares 13
Ventripoint Diagnostics Raises USD2.3 Million in Private Placement of Units 14
Ventripoint Diagnostics to Raise USD3.7 Million in Private Placement of Units 15
VentriPoint Diagnostics Raises USD1.75 Million in First Tranche of Private Placement of Units 16
VentriPoint Diagnostics Completes Second Tranche Of Private Placement Of Units For US$0.05 Million 18
VentriPoint Completes Second Tranche Of Private Placement Of Units For US$0.35 Million 20
VentriPoint Diagnostics Completes Final Tranche Private Placement Of Units For US$1.6 Million 21
VentriPoint Diagnostics Completes Final Tranche Of Non-Brokered Private Placement For US$2.5 Million 22
VentriPoint Diagnostics Completes Final Tranche Private Placement Of US$1.73 Million 23
Debt Offering 25
VentriPoint Diagnostics Completes Private Placement Of Debentures For US$0.5 Million 25
VentriPoint Diagnostics Completes Private Placement Of Debentures For US$0.5 Million 26
VentriPoint Diagnostics Completes Private Placement Of Debentures For US$0.3 Million 28
VentriPoint Diagnostics Completes Private Placement Of Debentures For US$0.75 Million 29
VentriPoint Diagnostics Ltd – Key Competitors 30
VentriPoint Diagnostics Ltd – Key Employees 31
VentriPoint Diagnostics Ltd – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Corporate Communications 33
Jul 20, 2017: A Third Highly Successful Ultrasound Executive joins Ventripoint 33
Jun 21, 2017: Highly Successful Global Industry Sales & Marketing Executives Hired by Ventripoint 34
Feb 15, 2016: Ventripoint Announces Change to the Board of Directors and Opening of Manufacturing Facility in Canada 35
Other Significant Developments 36
May 04, 2016: Ventripoint Diagnostic Provides Corporate Update 36
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
VentriPoint Diagnostics Ltd, Medical Equipment, Key Facts 2
VentriPoint Diagnostics Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
VentriPoint Diagnostics Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
VentriPoint Diagnostics Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
VentriPoint Diagnostics Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
VentriPoint Diagnostics Ltd, Deals By Market, 2011 to YTD 2017 8
VentriPoint Diagnostics Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
VentriPoint Diagnostics Enters into Licensing Agreement with University of Washington 10
VentriPoint Diagnostics Enters Into Co-Development Agreement For 2D Ultrasound-VMS 11
Ventripoint Diagnostics to Raise USD2.4 Million in Private Placement of Units 12
Ventripoint Diagnostics Raises USD0.2 Million in First Tranche Private Placement of Shares 13
Ventripoint Diagnostics Raises USD2.3 Million in Private Placement of Units 14
Ventripoint Diagnostics to Raise USD3.7 Million in Private Placement of Units 15
VentriPoint Diagnostics Raises USD1.75 Million in First Tranche of Private Placement of Units 16
VentriPoint Diagnostics Completes Second Tranche Of Private Placement Of Units For US$0.05 Million 18
VentriPoint Completes Second Tranche Of Private Placement Of Units For US$0.35 Million 20
VentriPoint Diagnostics Completes Final Tranche Private Placement Of Units For US$1.6 Million 21
VentriPoint Diagnostics Completes Final Tranche Of Non-Brokered Private Placement For US$2.5 Million 22
VentriPoint Diagnostics Completes Final Tranche Private Placement Of US$1.73 Million 23
VentriPoint Diagnostics Completes Private Placement Of Debentures For US$0.5 Million 25
VentriPoint Diagnostics Completes Private Placement Of Debentures For US$0.5 Million 26
VentriPoint Diagnostics Completes Private Placement Of Debentures For US$0.3 Million 28
VentriPoint Diagnostics Completes Private Placement Of Debentures For US$0.75 Million 29
VentriPoint Diagnostics Ltd, Key Competitors 30
VentriPoint Diagnostics Ltd, Key Employees 31
VentriPoint Diagnostics Ltd, Subsidiaries 32

★海外企業調査レポート[VentriPoint Diagnostics Ltd-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Triumph Group Inc:企業のM&A・事業提携・投資動向
    Triumph Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Triumph Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Bioderm Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bioderm Inc (Bioderm) is a medical equipment company that manufactures designs, and markets hydrocolloid products. The company manufactures hydrocolloid products for urinary management, securement, infection control, and skin protection. Its products include cathgrip, bioplus+, freederm, men …
  • Aramark Services Inc (ARMK):企業の財務・戦略的SWOT分析
    Aramark Services Inc (ARMK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Wellcome Trust Sanger Institute-製薬・医療分野:企業M&A・提携分析
    Summary Wellcome Trust Sanger Institute (Sanger Institute), a subsidiary of Genome Research Ltd is a genomic discovery and research centre that carries out research and development in the areas of cellular and human genetics and infection genomics. It also provides postgraduate training on research …
  • Clean Harbors, Inc. (CLH):企業の財務・戦略的SWOT分析
    Clean Harbors, Inc. (CLH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Ansaldo Thomassen B.V.:企業の戦略的SWOT分析
    Ansaldo Thomassen B.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Hankyu Hanshin Holdings, Inc.:企業の戦略・SWOT・財務情報
    Hankyu Hanshin Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hankyu Hanshin Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • ProvInce of Manitoba:企業の戦略的SWOT分析
    ProvInce of Manitoba - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Seattle Genetics Inc (SGEN):企業の財務・戦略的SWOT分析
    Seattle Genetics Inc (SGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Besins Healthcare SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Besins Healthcare SA (Besins) is a pharmaceutical company that develops drugs for the well-being of men and women. The company offers AndroGel, a topical testosterone gel for hypogonadism. It also provides Oestrogel, a transdermal estradiol gel. Besins’ women's health products are used for t …
  • Cinemark Holdings Inc (CNK):企業の財務・戦略的SWOT分析
    Cinemark Holdings Inc (CNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Xvivo Perfusion AB (XVIVO):企業の財務・戦略的SWOT分析
    Summary Xvivo Perfusion AB (Xvivo) is a medical technology company that provides organ transplantation solutions. The company develops organ preservation products such as perfadex and silicone tubing sets and normothermic perfusion products. It offers normothermic perfusion products such as STEEN so …
  • China Health Group Inc (8225):企業の財務・戦略的SWOT分析
    China Health Group Inc (8225) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Exact Holding N.V.:企業の戦略的SWOT分析
    Exact Holding N.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Black Hills Corporation (BKH)-石油・ガス分野:企業M&A・提携分析
    Summary Black Hills Corporation (BHC) is a vertically-integrated energy company which offers electricity and natural gas. The company produces, transmits, and distributes electricity; and sells natural gas on retail and wholesale basis. It generates electricity from natural gas, coal, diesel oil, an …
  • Etablissementen Franz Colruyt NV (COLR):企業の財務・戦略的SWOT分析
    Etablissementen Franz Colruyt NV (COLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Oswaldo Cruz Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary Oswaldo Cruz Foundation (Oswaldo Cruz) is a provider of research and development in biological sciences. It offers research programs and technological development projects in vaccines production, medications, drugs, reagents and diagnostic kits. The foundation provides research in experiment …
  • Talon Metals Corp.
    Talon Metals Corp. - Strategy, SWOT and Corporate Finance Report Summary Talon Metals Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Direct Energy Marketing Ltd:電力:M&Aディール及び事業提携情報
    Summary Direct Energy Marketing Ltd (Direct Energy), a subsidiary of Centrica plc, is a provider of energy and energy-related services. The company supplies, transports, and distributes natural gas and electricity. Direct Energy also installs and maintains heating, ventilation and air conditioning ( …
  • Capital Senior Living Corp (CSU):製薬・医療:M&Aディール及び事業提携情報
    Summary Capital Senior Living Corp (Capital Senior Living) is engaged in providing residential communities for elderly population. The company offers various living accommodations and supportive services including senior living services, independent living services, assisted living services includin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆